Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Clinical Trial ID NCT01313377

Rank	Title	Journal	Year	PubWeight™‹?›
1	Trial watch: Chemotherapy with immunogenic cell death inducers.	Oncoimmunology	2012	1.33
2	Intrahepatic cholangiocarcinoma: expert consensus statement.	HPB (Oxford)	2015	1.08
3	Gallbladder Cancer in the 21st Century.	J Oncol	2015	1.02
4	Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram.	Ann Oncol	2015	0.89
5	Current therapy and future directions in biliary tract malignancies.	Curr Treat Options Oncol	2013	0.86
6	Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial.	BMC Cancer	2015	0.84
7	Adjuvant treatment in biliary tract cancer: to treat or not to treat?	World J Gastroenterol	2012	0.83
8	Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.	Oncologist	2012	0.82
9	Consensus conference on intrahepatic cholangiocarcinoma.	HPB (Oxford)	2015	0.75
10	Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models.	J Am Coll Surg	2016	0.75